HuiMei Technology Secures RMB 70 Million Investment from New Era Capital, Completing Series D Funding Round at RMB 370 Million

Recently, NRL Capital disbursed an investment of RMB 70 million to Dr. Mayson, bringing the cumulative funding amount of Dr. Mayson's Series D round to RMB 370 million.

In September 2023, Dr. Mayson completed the main portion of its Series D financing, securing over RMB 300 million. The round was led by Zhongding Capital, with participation from renowned investment institutions including Runzhang Venture Capital, Suzhou Yihe, and Qiming Venture Partners.

NRL Capital is an investment and fund management platform that unites top-tier domestic and international industrial resources with long-term capital. It features interconnected capabilities in funds of funds, direct investment, and secondary private equity transactions, driven by a dual-engine model of onshore RMB and offshore USD. The firm focuses on sectors such as healthcare, semiconductors and intelligent manufacturing, new energy and carbon neutrality, and consumer technology, fostering mutual success with entrepreneurs and empowering Chinese enterprises in their global expansion.

Founded in 2015, Huimei Technology adheres to the philosophy that “quality is life,” dedicating itself to leveraging Clinical Decision Support System (CDSS) technology to enhance healthcare quality and safeguard patient safety. Dr. Mayson, the core hospital-side application of Huimei’s AI medical solutions, integrates PDCA process management with CDSS technology. By providing real-time data analysis and intelligent in-process alerts, it establishes a closed-loop quality control system across clinical decision-making, medical record front pages and ongoing charts, single-disease quality management and data reporting, clinical risk early warning, and DRG/DIP cost management, thereby effectively improving healthcare quality. As of the end of 2023, Huimei’s AI medical solutions had been implemented in nearly 800 hospitals, including 42 institutions ranked among the Fudan University Top 100 Hospitals, building an intelligent protective shield for healthcare quality and patient safety.